Literature DB >> 28518098

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells.

Huan-Huan Wei1, Yuanlong Liu1, Yang Wang2, Qianyun Lu1, Xuerong Yang1, Jiefu Li1, Zefeng Wang3.   

Abstract

The processing of most eukaryotic RNAs is mediated by RNA Binding Proteins (RBPs) with modular configurations, including an RNA recognition module, which specifically binds the pre-mRNA target and an effector domain. Previously, we have taken advantage of the unique RNA binding mode of the PUF domain in human Pumilio 1 to generate a programmable RNA binding scaffold, which was used to engineer various artificial RBPs to manipulate RNA metabolism. Here, a detailed protocol is described to construct Engineered Splicing Factors (ESFs) that are specifically designed to modulate the alternative splicing of target genes. The protocol includes how to design and construct a customized PUF scaffold for a specific RNA target, how to construct an ESF expression plasmid by fusing a designer PUF domain and an effector domain, and how to use ESFs to manipulate the splicing of target genes. In the representative results of this method, we have also described the common assays of ESF activities using splicing reporters, the application of ESF in cultured human cells, and the subsequent effect of splicing changes. By following the detailed protocols in this report, it is possible to design and generate ESFs for the regulation of different types of Alternative Splicing (AS), providing a new strategy to study splicing regulation and the function of different splicing isoforms. Moreover, by fusing different functional domains with a designed PUF domain, researchers can engineer artificial factors that target specific RNAs to manipulate various steps of RNA processing.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28518098      PMCID: PMC5565118          DOI: 10.3791/54967

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  34 in total

1.  General and specific functions of exonic splicing silencers in splicing control.

Authors:  Zefeng Wang; Xinshu Xiao; Eric Van Nostrand; Christopher B Burge
Journal:  Mol Cell       Date:  2006-06-22       Impact factor: 17.970

2.  SRSF1-Regulated Alternative Splicing in Breast Cancer.

Authors:  Olga Anczuków; Martin Akerman; Antoine Cléry; Jie Wu; Chen Shen; Nitin H Shirole; Amanda Raimer; Shuying Sun; Mads A Jensen; Yimin Hua; Frédéric H-T Allain; Adrian R Krainer
Journal:  Mol Cell       Date:  2015-10-01       Impact factor: 17.970

Review 3.  Aberrant and alternative splicing in cancer.

Authors:  Julian P Venables
Journal:  Cancer Res       Date:  2004-11-01       Impact factor: 12.701

4.  The gene encoding the splicing factor SF2/ASF is a proto-oncogene.

Authors:  Rotem Karni; Elisa de Stanchina; Scott W Lowe; Rahul Sinha; David Mu; Adrian R Krainer
Journal:  Nat Struct Mol Biol       Date:  2007-02-18       Impact factor: 15.369

5.  Identification of alternative splicing markers for breast cancer.

Authors:  Julian P Venables; Roscoe Klinck; Anne Bramard; Lyna Inkel; Geneviève Dufresne-Martin; ChuShin Koh; Julien Gervais-Bird; Elvy Lapointe; Ulrike Froehlich; Mathieu Durand; Daniel Gendron; Jean-Philippe Brosseau; Philippe Thibault; Jean-Francois Lucier; Karine Tremblay; Panagiotis Prinos; Raymund J Wellinger; Benoit Chabot; Claudine Rancourt; Sherif Abou Elela
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

6.  An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype.

Authors:  Irina M Shapiro; Albert W Cheng; Nicholas C Flytzanis; Michele Balsamo; John S Condeelis; Maja H Oktay; Christopher B Burge; Frank B Gertler
Journal:  PLoS Genet       Date:  2011-08-18       Impact factor: 5.917

Review 7.  Sequence-specific binding of single-stranded RNA: is there a code for recognition?

Authors:  Sigrid D Auweter; Florian C Oberstrass; Frédéric H-T Allain
Journal:  Nucleic Acids Res       Date:  2006-09-18       Impact factor: 16.971

8.  RNA splicing is a primary link between genetic variation and disease.

Authors:  Yang I Li; Bryce van de Geijn; Anil Raj; David A Knowles; Allegra A Petti; David Golan; Yoav Gilad; Jonathan K Pritchard
Journal:  Science       Date:  2016-04-28       Impact factor: 47.728

9.  Intronic splicing enhancers, cognate splicing factors and context-dependent regulation rules.

Authors:  Yang Wang; Meng Ma; Xinshu Xiao; Zefeng Wang
Journal:  Nat Struct Mol Biol       Date:  2012-09-16       Impact factor: 15.369

Review 10.  Aberrant alternative splicing is another hallmark of cancer.

Authors:  Michael Ladomery
Journal:  Int J Cell Biol       Date:  2013-09-11
View more
  1 in total

1.  [Construction of an adenovirus vector expressing engineered splicing factor for regulating alternative splicing of YAP1 in neonatal rat cardiomyocytes].

Authors:  Y Li; Q Zhao; X Song; J Song
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-07-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.